|
|||||
|
|

Scientific consulting firm Exponent (NASDAQ:EXPO) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 9.6% year on year to $137.1 million. Its GAAP profit of $0.55 per share was 8.1% above analysts’ consensus estimates.
Is now the time to buy EXPO? Find out in our full research report (it’s free for active Edge members).
Exponent’s third quarter performance was led by robust demand for its dispute-related consulting work, particularly in the energy, transportation, life sciences, and construction sectors. Management highlighted that reactive projects—those addressing urgent client challenges such as litigation or failure analysis—were the primary growth driver, while proactive risk management and regulatory consulting also contributed, especially in utilities and chemicals. CEO Catherine Corrigan noted, “Our diversified portfolio and deep technical capabilities position us well to capture this demand and deliver meaningful value for our clients.” Management did acknowledge a slowdown in consumer electronics activity, though they observed signs of improvement as the quarter ended.
Looking forward, Exponent’s growth strategy is centered on continued investment in talent and expanding expertise in emerging areas such as artificial intelligence, digital health, and advanced vehicle technologies. Management emphasized that hiring will be targeted toward segments showing the strongest demand, with Corrigan outlining, “Our philosophy remains the same in terms of targeting the recruiting toward the areas where we are seeing the growth.” The company expects utilization and realized rates to return to historical ranges, with ongoing regulatory and industry shifts providing new opportunities, but also acknowledging that headwinds such as changes in work mix and increased junior hiring could moderate rate increases.
Exponent’s management attributed Q3 growth to elevated demand for dispute consulting and risk management, while investments in hiring and technology supported expansion in targeted sectors. The company’s proactive and reactive service mix played a notable role in shaping results.
Exponent’s outlook is shaped by targeted hiring, sector-specific growth, and evolving demand for complex consulting, while margin expectations normalize as hiring ramps up and work mix evolves.
In the coming quarters, our analysts will be closely tracking (1) the pace and effectiveness of Exponent’s hiring in high-demand sectors like AI and digital health, (2) the recovery in proactive consulting, particularly in consumer electronics, and (3) the firm’s ability to sustain utilization and margin levels as work mix shifts. Additional attention will be paid to the influence of regulatory changes and macroeconomic factors on client consulting demand.
Exponent currently trades at $66.65, in line with $66.79 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free for active Edge members).
When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.
Don’t let fear keep you from great opportunities and take a look at Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Oct-31 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-28 | |
| Oct-23 | |
| Oct-09 | |
| Sep-29 | |
| Sep-23 | |
| Sep-22 | |
| Sep-12 | |
| Sep-10 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite